维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Kummer RR"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombi-nant tissue plasminogen activator:A secondary analysis of the European-Australa-sian Acute Stroke Study (ECASS II)显示文摘	Larrue V von Kummer RR Muller A Bluhmki E		0，，：	1
2	Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS Ⅱ) 显示文摘	Larrue V Kummer RR Mfiller A	2001	Stroke2001，32，2：	1
3	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ)显示文摘	von Kummer RR Müller A	2001	Stroke2001，32，：	1
4	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS lI ) 显示文摘	Larrue V von Kummer RR MUller A	2001	Stroke2001，32，2：	1
5	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS I1 ) 显示文摘	Larrue V yon Kummer RR Muller A	2001	Stroke2001，32，：	1
6	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ ) 显示文摘	Larrue V van Kummer RR Muller A	2001	Stroke2001，32，2：	1
7	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen acti- vator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ ) 显示文摘	Larrue V yon Kummer RR Muller A	2001	Stroke2001，32，2：	1
8	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute stroke study (ECASS-Ⅱ)显示文摘	Larrut V von Kummer RR Muller A		0，，02：	1
9	Risk farctors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Stude(ECASS Ⅱ)显示文摘	Larrue V von Kummer RR Muller A	2001	Stroke2001，32，2：	1
10	Risk factors for severe hemorrhagictransformation in ischemic stroke patients treated with recombinanttissue plasminogen activator:a secondary analysis of the EuropeanAustralasian Acute Stroke Study(ECASS II)显示文摘	Larrue V von Kummer RR	2001	Stroke2001，32，2：	1
11	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS Ⅱ ) 显示文摘	Larrue V von Kummer RR Mailer A	2001	Stroke2001，32，：	1
12	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study(EAASS II)显示文摘	Larrue V Kummer RR Muller A	2001	Stroke2001，32，：	1
13	Risk factors for severe hemorrhagic transformation in ischemie stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS Ⅱ) 显示文摘	Larrue V yon Kummer RR MOiler A	2001	Stroke2001，32，2：	1
14	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the EuropeanAustralasian Acute Stoke Study(ECASS Ⅱ)显示文摘	Larrue V von Kummer RR Muller A	2001	Stroke2001，32，2：	1
15	Risk factors of severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European - Australasian Acute Stroke Study (ECASS Ⅱ ) 显示文摘	Larrue V yon Kummer RR MUller A	2001	Stroke2001，32，2：	1
16	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASB II) 显示文摘	Larrue V von Kummer RR Muller A	2001	Stroke2001，32，：	1
17	Risk factors forsevere hemorrhagic transformation in ischemic stroke patientstreated with recombinant tissue plasminogen activator:asecondary analysis of the European-Australasian Acute StrokeStudy(ECASSII)显示文摘	Larrue V von Kummer RR Müller A et al	2001	Stroke2001，32，2：	1
18	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study (ECASS H ) 显示文摘	Larrue V yon Kummer RR M Li ller A	2001	Stroke2001，32，2：	1
19	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European -Australasian Acute Stroke Study (ECASS II)显示文摘	Larrue V von Kummer RR Muller A	2001	Stroke2001，32，：	1
20	Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study(ECASS Ⅱ)显示文摘	Larrue V yon Kummer RR Muller A	2001	Stroke2001，32，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示